-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G50R3Qd3MwKy9pHvrpC65v+6VTxkk/RoaBCVSqhzIhVL35bf8/RY55HF4UNVL8nT 5cFcQJO3qi/8/guo9MK2vA== 0001144204-09-008627.txt : 20090217 0001144204-09-008627.hdr.sgml : 20090216 20090217115439 ACCESSION NUMBER: 0001144204-09-008627 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090217 DATE AS OF CHANGE: 20090217 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Bentwich Isaac CENTRAL INDEX KEY: 0001426673 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: BUSINESS PHONE: 972-8-948-4755 MAIL ADDRESS: STREET 1: C/O ROSETTA GENOMICS LTD. STREET 2: 10 PLAUT STREET, SCIENCE PARK, POB 4059 CITY: REHOVOV STATE: L3 ZIP: 76706 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Rosetta Genomics Ltd. CENTRAL INDEX KEY: 0001362959 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-82715 FILM NUMBER: 09608888 BUSINESS ADDRESS: STREET 1: 10 PLAUT STREET, SCIENCE PARK STREET 2: POB 4059 CITY: REHOVOT STATE: L3 ZIP: 76706 BUSINESS PHONE: 972-8-9484755 MAIL ADDRESS: STREET 1: 10 PLAUT STREET, SCIENCE PARK STREET 2: POB 4059 CITY: REHOVOT STATE: L3 ZIP: 76706 SC 13G/A 1 v140381_sc13ga.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) (Amendment No. 1) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 ROSETTA GENOMICS LTD. - -------------------------------------------------------------------------------- (Name of Issuer) Ordinary Shares, par value NIS 0.01 per share - -------------------------------------------------------------------------------- (Title of Class of Securities) M82183 100 - -------------------------------------------------------------------------------- (CUSIP Number) December 31, 2008 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 6 pages ===================== ================= CUSIP NO. M82183 100 13G Page 2 of 6 Pages ===================== ================= ============= ================================================================== 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Isaac Bentwich, M.D. - ------------- ------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - ------------- ------------------------------------------------------------------ 3 SEC USE ONLY - ------------- ------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION Israel ======================================= ====== ================================= 5 SOLE VOTING POWER 1,052,877 ordinary shares ------ --------------------------------------- 6 SHARED VOTING POWER NUMBER OF SHARES 549,531 ordinary shares BENEFICIALLY ------ --------------------------------------- OWNED BY 7 SOLE DISPOSITIVE POWER EACH 1,052,877 ordinary shares REPORTING PERSON WITH ------ --------------------------------------- 8 SHARED DISPOSITIVE POWER 549,531 ordinary shares ============ =================================================================== 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,602,408 ordinary shares - ------------ ------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] - ------------ ------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 13.2% - ------------ ------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN ============ =================================================================== *SEE INSTRUCTIONS BEFORE FILLING OUT! Page 2 of 6 pages Item 1(a). Name of Issuer: Rosetta Genomics Ltd. Item 1(b). Address of Issuer's Principal Executive Offices: 10 Plaut Street, Science Park Rehovot 76706 POB 4059, Israel Item 2(a). Name of Person Filing: Isaac Bentwich, M.D. Item 2(b). Address of Principal Business Office or, if None, Residence: c/o Rosetta Genomics Ltd. 10 Plaut Street, Science Park Rehovot 76706 POB 4059, Israel Item 2(c). Citizenship: Israel Item 2(d). Title of Class of Securities: Ordinary shares, par value NIS 0.01 per share Item 2(e). CUSIP Number: M82183 100 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Exchange Act. (b) [ ] Bank as defined in Section 3(a)(6) of the Exchange Act. (c) [ ] Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940. Page 3 of 6 pages (e) [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E). (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F). (g) [ ] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G). (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act. (j) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). Item 4. Ownership (a) Amount beneficially owned: 1,602,408 ordinary shares. Consists of (i) 1,052,877 ordinary shares directly owned by Dr. Bentwich, (ii) 549,531 ordinary shares held by Harmonia 2000. Harmonia 2000 is an Israeli non-profit association, of which Dr. Bentwich is one of seven members, and one of three members of its managing board. The members of Harmonia 2000's managing board control the securities held by Harmonia 2000, and Dr. Bentwich is therefore deemed to beneficially own the securities owned by Harmonia 2000. Dr. Bentwich disclaims any beneficial ownership of the securities owned by Harmonia 2000. Dr. Bentwich's ownership changed as the result of the dissolution of Bentwich Innovations Ltd., which held 1,121,036 ordinary shares, and the distribution of 1,008,932 shares to Dr. Bentwich as his direct proportion of that entity's holdings; and the dissolution of Bentwich Holdings Ltd., which held 175,781 ordinary shares, and the distribution of 43,945 shares to Dr. Bentwich as his direct proportion of that entity's holdings. (b) Percent of class: 13.2% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 1,052,877 ordinary shares directly owned by Dr. Bentwich. (ii) shared power to vote or to direct the vote: 549,531 ordinary shares. Consists of the 549,531 ordinary shares held by Harmonia 2000. (iii) sole power to dispose or to direct the disposition of: 1,052,877 ordinary shares directly owned by Dr. Bentwich. Page 4 of 6 pages (iv) shared power to dispose or to direct the disposition of: 549,531 ordinary shares. Consists of the 549,531 ordinary shares held by Harmonia 2000. Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Not Applicable Item 6. Ownership of More than Five Percent on Behalf of Another Person Not Applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company Not Applicable Item 8. Identification and Classification of Members of the Group Not Applicable Item 9. Notice of Dissolution of Group Not Applicable Item 10. Certification Not Applicable Page 5 of 6 pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 16, 2009 /s/ Isaac Bentwich ------------------------- Isaac Bentwich, M.D. Page 6 of 6 pages -----END PRIVACY-ENHANCED MESSAGE-----